News Medical on MSN17h
AI model identifies potential risk genes for Parkinson's diseaseResearchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
19hon MSN
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...
Leprosy, caused by Mycobacterium leprae, is a chronic but curable infectious disease affecting the skin, nerves, and ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
The neurorehabilitation devices market is expected to grow from US$ 2.73 billion in 2023, with CAGR of 12.7% during 2023–2031 ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Stockhead on MSN6h
Health Check: Alterity angles for fast-track FDA approval after positive trial results tackling Parkinson’s-like disorderFollowing “positive” top-line phase II trial results, neurodegenerative disease house Alterity Therapeutics (ASX:ATH) will ...
Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...
U.S. Department of Defense awards $4 million to researchers at OHSU, University of Washington, VA Portland, VA Puget Sound to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback